The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
Open accessAbstract
Cellular messenger RNA (mRNA) of higher eukaryotes and many viral RNAs are methylated at the N-7 and 2′-O positions of the 5′ guanosine cap by specific nuclear and cytoplasmic methyltransferases (MTases), respectively. Whereas N-7 methylation is essential for RNA translation and stability, the function of 2′-O methylation has remained uncertain since its discovery 35 years ago. Here we show that a West Nile virus (WNV) mutant (E218A) that lacks 2′-O MTase activity was attenuated in wild-type primary cells and mice but was pathogenic in the absence of type I interferon (IFN) signalling. 2′-O methylation of viral RNA did not affect IFN induction in WNV-infected fibroblasts but instead modulated the antiviral effects of IFN-induced proteins with tetratricopeptide repeats (IFIT), which are interferon-stimulated genes (ISGs) implicated in regulation of protein translation. Poxvirus and coronavirus mutants that lacked 2′-O MTase activity similarly showed enhanced sensitivity to the antiviral actions of IFN and, specifically, IFIT proteins. Our results demonstrate that the 2′-O methylation of the 5′ cap of viral RNA functions to subvert innate host antiviral responses through escape of IFIT-mediated suppression, and suggest an evolutionary explanation for 2′-O methylation of cellular mRNA: to distinguish self from non-self RNA. Differential methylation of cytoplasmic RNA probably serves as an example for pattern recognition and restriction of propagation of foreign viral RNA in host cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
Sumpter, R., Loo, Y.-M., Foy, E., Li, K., Yoneyama, M., Fujita, T., Lemon, S. M., & Gale, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2689-2699.2005 · Cited by 898
Methylated nucleotides block 5′ terminus of HeLa cell messenger RNA
Wei, C.-M., Gershowitz, A., & Moss, B. (1975) · Cell · doi:10.1016/0092-8674(75)90158-0 · Cited by 750
Samuel, M. A., & Diamond, M. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13350-13361.2005 · Cited by 430
Self-citationStructure and Function of Flavivirus NS5 Methyltransferase
Zhou, Y., Ray, D., Zhao, Y., Dong, H., Ren, S., Li, Z., Guo, Y., Bernard, K. A., Shi, P.-Y., & Li, H. (2007) · Journal of Virology · doi:10.1128/jvi.02704-06 · Cited by 406
Self-citationViral and cellular mRNA capping: Past and prospects
Furuichi, Y., & Shatkin, A. J. (2000) · Advances in Virus Research · doi:10.1016/s0065-3527(00)55003-9 · Cited by 404
Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection
Daffis, S., Samuel, M. A., Suthar, M. S., Gale, M., & Diamond, M. S. (2008) · Journal of Virology · doi:10.1128/jvi.00935-08 · Cited by 358
Self-citationDecroly, E., Imbert, I., Coutard, B., Bouvet, M., Selisko, B., Alvarez, K., Gorbalenya, A. E., Snijder, E. J., & Canard, B. (2008) · Journal of Virology · doi:10.1128/jvi.00407-08 · Cited by 252
Zhang, Y., Burke, C. W., Ryman, K. D., & Klimstra, W. B. (2007) · Journal of Virology · doi:10.1128/jvi.01282-07 · Cited by 241
Self-citationDaffis, S., Samuel, M. A., Keller, B. C., Gale, M., & Diamond, M. S. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030106 · Cited by 194
Self-citation
Cited by
Coronavirus biology and replication: implications for SARS-CoV-2
V’kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00468-6 · Cited by 3,197
Self-citationInterferon-stimulated genes and their antiviral effector functions
Schoggins, J. W., & Rice, C. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.008 · Cited by 1,289
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Self-citationAstuti, I., & Ysrafil (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,070
Reversible methylation of m6Am in the 5′ cap controls mRNA stability
Mauer, J., Luo, X., Blanjoie, A., Jiao, X., Grozhik, A. V., Patil, D. P., Linder, B., Pickering, B. F., Vasseur, J.-J., Chen, Q., et al. (2017) · Nature · doi:10.1038/nature21022 · Cited by 1,062
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., & Colonna, M. (2012) · Nature Immunology · doi:10.1038/ni.2360 · Cited by 1,011
Self-citationType I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
mRNA capping: biological functions and applications
Ramanathan, A., Robb, G. B., & Chan, S.-H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw551 · Cited by 898
Weiss, S. R., & Leibowitz, J. L. (2011) · Advances in Virus Research · doi:10.1016/b978-0-12-385885-6.00009-2 · Cited by 896
The broad-spectrum antiviral functions of IFIT and IFITM proteins
Diamond, M. S., & Farzan, M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3344 · Cited by 849
Self-citationZüst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B. W., Ziebuhr, J., Szretter, K. J., Baker, S. C., Barchet, W., Diamond, M. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.1979 · Cited by 811
Self-citationA complement–microglial axis drives synapse loss during virus-induced memory impairment
Vasek, M. J., Garber, C., Dorsey, D., Durrant, D. M., Bollman, B., Soung, A., Yu, J., Perez-Torres, C., Frouin, A., Wilton, D. K., et al. (2016) · Nature · doi:10.1038/nature18283 · Cited by 671
Zika virus: History, emergence, biology, and prospects for control
Weaver, S. C., Costa, F., Garcia-Blanco, M. A., Ko, A. I., Ribeiro, G. S., Saade, G., Shi, P.-Y., & Vasilakis, N. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.03.010 · Cited by 653
Self-citationJensen, S., & Thomsen, A. R. (2012) · Journal of Virology · doi:10.1128/jvi.05738-11 · Cited by 604
Discriminating self from non-self in nucleic acid sensing
Schlee, M., & Hartmann, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.78 · Cited by 593
The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing
Snijder, E. J., Decroly, E., & Ziebuhr, J. (2016) · Advances in Virus Research · doi:10.1016/bs.aivir.2016.08.008 · Cited by 558
Structural biology of SARS-CoV-2 and implications for therapeutic development
Yang, H., & Rao, Z. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00630-8 · Cited by 548
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 532
Romano, M., Ruggiero, A., Squeglia, F., Maga, G., & Berisio, R. (2020) · Cells · doi:10.3390/cells9051267 · Cited by 527
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Miorin, L., Kehrer, T., Sanchez-Aparicio, M. T., Zhang, K., Cohen, P., Patel, R. S., Cupic, A., Makio, T., Mei, M., Moreno, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016650117 · Cited by 527
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Yuen, C.-K., Lam, J.-Y., Wong, W.-M., Mak, L.-F., Wang, X., Chu, H., Cai, J.-P., Jin, D.-Y., To, K. K.-W., Chan, J. F.-W., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1780953 · Cited by 524
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514
Conventional and unconventional mechanisms for capping viral mRNA
Decroly, E., Ferron, F., Lescar, J., & Canard, B. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2675 · Cited by 490
Self-amplifying RNA vaccines for infectious diseases
Bloom, K., van den Berg, F., & Arbuthnot, P. (2021) · Gene Therapy · doi:10.1038/s41434-020-00204-y · Cited by 487
IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
Pichlmair, A., Lassnig, C., Eberle, C.-A., Górna, M. W., Baumann, C. L., Burkard, T. R., Bürckstümmer, T., Stefanovic, A., Krieger, S., Bennett, K. L., et al. (2011) · Nature Immunology · doi:10.1038/ni.2048 · Cited by 484
Coronaviruses: An RNA proofreading machine regulates replication fidelity and diversity
Denison, M. R., Graham, R. L., Donaldson, E. F., Eckerle, L. D., & Baric, R. S. (2011) · RNA Biology · doi:10.4161/rna.8.2.15013 · Cited by 476
A Comprehensive Review of mRNA Vaccines
Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457
Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids
Tan, X., Sun, L., Chen, J., & Chen, Z. J. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095605 · Cited by 443
The RNA modification N6-methyladenosine as a novel regulator of the immune system
Shulman, Z., & Stern-Ginossar, N. (2020) · Nature Immunology · doi:10.1038/s41590-020-0650-4 · Cited by 426
Reversible RNA adenosine methylation in biological regulation
Jia, G., Fu, Y., & He, C. (2013) · Trends in Genetics · doi:10.1016/j.tig.2012.11.003 · Cited by 424
Ten Strategies of Interferon Evasion by Viruses
García-Sastre, A. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.012 · Cited by 423
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Totura, A. L., & Baric, R. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.04.004 · Cited by 415
RNA m6A methylation across the transcriptome
Sendinc, E., & Shi, Y. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.01.006 · Cited by 411
Dynamics of Human and Viral RNA Methylation during Zika Virus Infection
Lichinchi, G., Zhao, B. S., Wu, Y., Lu, Z., Qin, Y., He, C., & Rana, T. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.002 · Cited by 405
Devarkar, S. C., Wang, C., Miller, M. T., Ramanathan, A., Jiang, F., Khan, A. G., Patel, S. S., & Marcotrigiano, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515152113 · Cited by 357
Anderson, B. R., Muramatsu, H., Jha, B. K., Silverman, R. H., Weissman, D., & Kariko, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr586 · Cited by 356
Shaw, A. E., Hughes, J., Gu, Q., Behdenna, A., Singer, J. B., Dennis, T., Orton, R. J., Varela, M., Gifford, R. J., Wilson, S. J., et al. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2004086 · Cited by 352
Ten years of dengue drug discovery: Progress and prospects
Lim, S. P., Wang, Q.-Y., Noble, C. G., Chen, Y.-L., Dong, H., Zou, B., Yokokawa, F., Nilar, S., Smith, P., Beer, D., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.013 · Cited by 350
Self-citationChen, Y., Su, C., Ke, M., Jin, X., Xu, L., Zhang, Z., Wu, A., Sun, Y., Yang, Z., Tien, P., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002294 · Cited by 349
Bouvet, M., Imbert, I., Subissi, L., Gluais, L., Canard, B., & Decroly, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201130109 · Cited by 345
RNA modifications in physiology and disease: towards clinical applications
Delaunay, S., Helm, M., & Frye, M. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00645-2 · Cited by 345
Biochemistry and Molecular Biology of Flaviviruses
Barrows, N. J., Campos, R. K., Liao, K.-C., Prasanth, K. R., Soto-Acosta, R., Yeh, S.-C., Schott-Lerner, G., Pompon, J., Sessions, O. M., Bradrick, S. S., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00719 · Cited by 341
Interferon-Induced Ifit Proteins: Their Role in Viral Pathogenesis
Fensterl, V., & Sen, G. C. (2015) · Journal of Virology · doi:10.1128/jvi.02744-14 · Cited by 339
Self-citationGuy, B., Barrere, B., Malinowski, C., Saville, M., Teyssou, R., & Lang, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.094 · Cited by 322
Molecular pathology of emerging coronavirus infections
Gralinski, L. E., & Baric, R. S. (2015) · The Journal of Pathology · doi:10.1002/path.4454 · Cited by 319
Schuberth-Wagner, C., Ludwig, J., Bruder, A. K., Herzner, A.-M., Zillinger, T., Goldeck, M., Schmidt, T., Schmid-Burgk, J. L., Kerber, R., Wolter, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.015 · Cited by 311
Lazear, H. M., Lancaster, A., Wilkins, C., Suthar, M. S., Huang, A., Vick, S. C., Clepper, L., Thackray, L., Brassil, M. M., Virgin, H. W., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003118 · Cited by 296
Self-citationCellular Self-Defense: How Cell-Autonomous Immunity Protects Against Pathogens
Randow, F., MacMicking, J. D., & James, L. C. (2013) · Science · doi:10.1126/science.1233028 · Cited by 292
The Antiviral Innate Immune Response in Fish: Evolution and Conservation of the IFN System
Langevin, C., Aleksejeva, E., Passoni, G., Palha, N., Levraud, J.-P., & Boudinot, P. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.09.033 · Cited by 292
Nm-seq maps 2′-O-methylation sites in human mRNA with base precision
Dai, Q., Moshitch-Moshkovitz, S., Han, D., Kol, N., Amariglio, N., Rechavi, G., Dominissini, D., & He, C. (2017) · Nature Methods · doi:10.1038/nmeth.4294 · Cited by 291
Yan, L., Ge, J., Zheng, L., Zhang, Y., Gao, Y., Wang, T., Huang, Y., Yang, Y., Gao, S., Li, M., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.016 · Cited by 289
Hartmann, G. (2017) · Advances in Immunology · doi:10.1016/bs.ai.2016.11.001 · Cited by 285
Alphavirus RNA synthesis and non-structural protein functions
Rupp, J. C., Sokoloski, K. J., Gebhart, N. N., & Hardy, R. W. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000249 · Cited by 285
Garber, C., Soung, A., Vollmer, L. L., Kanmogne, M., Last, A., Brown, J., & Klein, R. S. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0427-y · Cited by 272
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Gusev, E., Sarapultsev, A., Solomatina, L., & Chereshnev, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031716 · Cited by 281
Regulation and functions of non-m6A mRNA modifications
Sun, H., Li, K., Liu, C., & Yi, C. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00622-x · Cited by 278
Bidet, K., Dadlani, D., & Garcia-Blanco, M. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004242 · Cited by 276
N6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I
Lu, M., Zhang, Z., Xue, M., Zhao, B. S., Harder, O., Li, A., Liang, X., Gao, T. Z., Xu, Y., Zhou, J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0653-9 · Cited by 273
Self-citationKrafcikova, P., Silhan, J., Nencka, R., & Boura, E. (2020) · Nature Communications · doi:10.1038/s41467-020-17495-9 · Cited by 269
Immune Response to Dengue and Zika
Elong Ngono, A., & Shresta, S. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053142 · Cited by 268
Innate immune evasion strategies of DNA and RNA viruses
Beachboard, D. C., & Horner, S. M. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.015 · Cited by 265
Viperin: A Multifunctional, Interferon-Inducible Protein that Regulates Virus Replication
Seo, J.-Y., Yaneva, R., & Cresswell, P. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.11.004 · Cited by 254
Durbin, A. F., Wang, C., Marcotrigiano, J., & Gehrke, L. (2016) · mBio · doi:10.1128/mbio.00833-16 · Cited by 238
Kumar, P., Sweeney, T. R., Skabkin, M. A., Skabkina, O. V., Hellen, C. U. T., & Pestova, T. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1321 · Cited by 210
Innate immune restriction and antagonism of viral RNA lacking 2׳-O methylation
Hyde, J. L., & Diamond, M. S. (2015) · Virology · doi:10.1016/j.virol.2015.01.019 · Cited by 194
Self-citationMinnaert, A.-K., Vanluchene, H., Verbeke, R., Lentacker, I., De Smedt, S. C., Raemdonck, K., Sanders, N. N., & Remaut, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113900 · Cited by 157
CSF1R antagonism limits local restimulation of antiviral CD8+ T cells during viral encephalitis
Funk, K. E., & Klein, R. S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1397-4 · Cited by 156
Regulatory role of small nucleolar RNAs in human diseases
Stepanov, G. A., Filippova, J. A., Komissarov, A. B., Kuligina, E. V., Richter, V. A., & Semenov, D. V. (2015) · BioMed Research International · doi:10.1155/2015/206849 · Cited by 154
Nanomedicine-Based Approaches for mRNA Delivery
Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
Kang, D. D., Li, H., & Dong, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114961 · Cited by 100
SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential
Vithani, N., Ward, M. D., Zimmerman, M. I., Novak, B., Borowsky, J. H., Singh, S., & Bowman, G. R. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.03.024 · Cited by 84
Siegfried, A., Berchtold, S., Manncke, B., Deuschle, E., Reber, J., Ott, T., Weber, M., Kalinke, U., Hofer, M. J., Hatesuer, B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203305 · Cited by 70
AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
Trepte, P., Secker, C., Olivet, J., Blavier, J., Kostova, S., Maseko, S. B., Minia, I., Silva Ramos, E., Cassonnet, P., Golusik, S., et al. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00019-8 · Cited by 35
Metadata
- Authors
- Daffis, S., Szretter, K. J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.-Y., Schneller, S., Zust, R., Dong, H., Thiel, V., Sen, G. C., Fensterl, V., Klimstra, W. B., Pierson, T. C., Buller, R. M., Gale Jr, M., Shi, P.-Y., & Diamond, M. S.
- Venue
- Nature
- Published
- 2010-11-17
- Volume
- 468
- Issue
- 7322
- Pages
- 452-456
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2050843600
- Cited by
- 907
- References
- 23
- FWCI
- 15.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.